Crescita Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Crescita Therapeutics Inc
Access all reports
Crescita Therapeutics Inc. is a Canadian company engaged in the commercial dermatology sector. It specializes in both prescription and non-prescription skincare products aimed at treating various skin conditions and diseases. Crescita's product portfolio includes a notable prescription product, Pliaglis, which utilizes a proprietary phase-changing cream technology and is available in over 40 countries. The company is headquartered in Laval, Quebec, and its shares are listed on the Toronto Stock Exchange.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
CTX
Country
🇨🇦 Canada